Actionable news
All posts from Actionable news
Actionable news in ADAP: Adaptimmune Therapeutics PLC,

Adaptimmune to Report Second Quarter 2016 Financial Results on August 8, 2016

PHILADELPHIA and OXFORD, United Kingdom, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (ADAP), a leader in T-cell therapy to treat cancer, will announce financial results for the quarter ended June 30, 2016 before the open of the U.S. markets on Monday August 8, 2016. Following the announcement, the company will host a live teleconference and webcast at 8:00 a.m. Eastern Time (1:00 p.m. BST) on the same day at which time management will provide a business update and discuss the financial results for the second quarter of 2016.

The press release and the live webcast of the conference call will be available via in the investor section of Adaptimmune’s corporate website at An archive will be available after the call at the same address.

To participate in the live conference call, if preferred, please dial (877) 280-2296 (U.S.) or +44 (0)20 3427 1901 or 0800 279 4841 (United Kingdom). After placing the call, please ask to be joined into the Adaptimmune conference call and provide the confirmation code (7948131).

About Adaptimmune
Adaptimmune is a clinical stage biopharmaceutical company focused on novel...